Liver Disease
121 - 135 of
148 Results
Sort Results:
Article:
Xifaxan (rifaximin) now comes in a 550 mg tablet to prevent hepatic encephalopathy due to chronic liver disease
June 2010
Article:
Xifaxan (rifaximin) is now approved for preventing hepatic encephalopathy due to chronic liver disease
May 2010
Article:
The recent recall of Hydroxycut products is focusing new attention on the safety of dietary supplements
June 2009
Article:
A recent case of hepatitis is bringing up concerns about the safety of using red yeast rice supplements
December 2008
Article:
risk of renal impairment in patients taking an ACE inhibitor or ARB, diuretic, and NSAID
December 2006